Literature DB >> 14747019

Malaria immunity in infants: a special case of a general phenomenon?

Lars Hviid1, Trine Staalsoe.   

Abstract

Newborn infants in endemic areas are markedly resistant to Plasmodium falciparum malaria. Consequently, severe disease is rare during the first few months of life, and infections tend to be low density and relatively asymptomatic during this period. Although this is generally ascribed to passively transferred immunity, attempts to identify the targets and mechanisms of this protection have been unsuccessful. The implications of the hypothesis that the progression from resistance through susceptibility and back to resistance during infancy and early childhood reflects the gradual acquisition of IgG to variant surface antigens (VSAs), while protection from maternal VSA-specific IgG steadily fades, are discussed here.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747019     DOI: 10.1016/j.pt.2003.11.009

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  31 in total

1.  The Interaction between HIV and malaria in Africa.

Authors:  Miriam K Laufer; Christopher V Plowe
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

2.  How selection forces dictate the variant surface antigens used by malaria parasites.

Authors:  Maite Severins; Don Klinkenberg; Hans Heesterbeek
Journal:  J R Soc Interface       Date:  2011-07-06       Impact factor: 4.118

3.  Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family.

Authors:  Louise Joergensen; Louise Turner; Pamela Magistrado; Madeleine A Dahlbäck; Lasse S Vestergaard; John P Lusingu; Martha Lemnge; Ali Salanti; Thor G Theander; Anja T R Jensen
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

4.  Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.

Authors:  Mónica Guerra; Rita Neres; Patrícia Salgueiro; Cristina Mendes; Nicolas Ndong-Mabale; Pedro Berzosa; Bruno de Sousa; Ana Paula Arez
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

5.  High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.

Authors:  Thomas Jaenisch; Kirsten Heiss; Nico Fischer; Carolin Geiger; F Ralf Bischoff; Gerhard Moldenhauer; Leszek Rychlewski; Ali Sié; Boubacar Coulibaly; Peter H Seeberger; Lucjan S Wyrwicz; Frank Breitling; Felix F Loeffler
Journal:  Mol Cell Proteomics       Date:  2019-01-10       Impact factor: 5.911

6.  The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs.

Authors:  Lars M Joergensen; Ali Salanti; Tina Dobrilovic; Lea Barfod; Tue Hassenkam; Thor G Theander; Lars Hviid; David E Arnot
Journal:  Malar J       Date:  2010-04-19       Impact factor: 2.979

7.  Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria.

Authors:  Pamela A Magistrado; John Lusingu; Lasse S Vestergaard; Martha Lemnge; Thomas Lavstsen; Louise Turner; Lars Hviid; Anja T R Jensen; Thor G Theander
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

8.  Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania.

Authors:  Lasse S Vestergaard; John P Lusingu; Morten A Nielsen; Bruno P Mmbando; Daniel Dodoo; Bartholomew D Akanmori; Michael Alifrangis; Ib C Bygbjerg; Martha M Lemnge; Trine Staalsoe; Lars Hviid; Thor G Theander
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

9.  Unraveling the impact of malaria exposure before birth.

Authors:  Lars Hviid
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

Review 10.  The use of schools for malaria surveillance and programme evaluation in Africa.

Authors:  Simon Brooker; Jan H Kolaczinski; Carol W Gitonga; Abdisalan M Noor; Robert W Snow
Journal:  Malar J       Date:  2009-10-19       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.